{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:11:26Z","timestamp":1765728686305,"version":"3.32.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:00:00Z","timestamp":1541462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jsps.2018.11.002","type":"journal-article","created":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T16:32:09Z","timestamp":1541608329000},"page":"225-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Attitude and knowledge of Saudi community pharmacists towards use of proton pump inhibitors"],"prefix":"10.1007","volume":"27","author":[{"given":"Abdulaziz","family":"Alhossan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2455-6727","authenticated-orcid":false,"given":"Ziyad","family":"Alrabiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sultan","family":"Alghadeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salmeen","family":"Bablghaith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Wajid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Al-Arifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"6","key":"10.1016\/j.jsps.2018.11.002_b0005","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MOG.0b013e328358d5b9","article-title":"Proton pump inhibitors: potential adverse effects","volume":"28","author":"Abraham","year":"2012","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"5","key":"10.1016\/j.jsps.2018.11.002_b0010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s11096-015-0150-z","article-title":"The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors","volume":"37","author":"Boardman","year":"2015","journal-title":"Int. J. Clin. Pharm."},{"issue":"6","key":"10.1016\/j.jsps.2018.11.002_b0015","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1046\/j.1365-2036.1999.00524.x","article-title":"Survey on repeat prescribing for acid suppression medications in primary care in Cornwall and the Isles of Sicily","volume":"13","author":"Boutet","year":"1999","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jsps.2018.11.002_b0020","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0149-2918(01)80087-4","article-title":"Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials","volume":"23","author":"Caro","year":"2001","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jsps.2018.11.002_b0025","unstructured":"Egapal (omeprazole) [Italian summary of product characteristics], 2012. Sandoz SpA Largo U, Origgio, Italy."},{"key":"10.1016\/j.jsps.2018.11.002_b0030","doi-asserted-by":"crossref","unstructured":"French-Belgian Consensus Conference on Adult Gastro-oesophageal Reflux Disease \u2018Diagnosis and Treatment\u2019: report of a meeting held in Paris, France, on 21\u201322 January 1999, 2000. The Jury of the consensus conference. Eur. J. Gastroenterol. Hepatol. 12(1), 129\u201337.","DOI":"10.1097\/00042737-200012010-00024"},{"issue":"7","key":"10.1016\/j.jsps.2018.11.002_b0035","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s11606-013-2345-0","article-title":"Proton pump inhibitor prescriptions and subsequent use in US veterans diagnosed with gastroesophageal reflux disease","volume":"28","author":"Gawron","year":"2013","journal-title":"J. Gen. Int. Med."},{"issue":"Suppl.","key":"10.1016\/j.jsps.2018.11.002_b0040","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1038\/ajg.2009.49","article-title":"Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk","volume":"104","author":"Heidelbaugh","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jsps.2018.11.002_b0045","first-page":"e228","article-title":"Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting","volume":"16","author":"Heidelbaugh","year":"2010","journal-title":"Am. J. Manage. Care"},{"issue":"3","key":"10.1016\/j.jsps.2018.11.002_b0050","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11096-011-9489-y","article-title":"Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD","volume":"33","author":"Holtmann","year":"2011","journal-title":"Int. J. Clin. Pharm."},{"issue":"9","key":"10.1016\/j.jsps.2018.11.002_b0055","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s10620-008-0568-4","article-title":"Use of intravenous proton-pump inhibitors in a teaching hospital practice","volume":"54","author":"Hoover","year":"2009","journal-title":"Digest. Dis. Sci."},{"key":"10.1016\/j.jsps.2018.11.002_b0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cgh.2011.07.008","article-title":"Systematic review: patterns of proton pump inhibitor use and adherence in gastroesophageal reflux disease","volume":"10","author":"Hungin","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jsps.2018.11.002_b0065","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2008.08.045","article-title":"American gastroenterological association medical position statement on the management of gastroesophageal reflux disease","volume":"135","author":"Kahrilas","year":"2008","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.jsps.2018.11.002_b0070","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archinternmed.2010.64","article-title":"Failing the acid test: benefits of proton pump inhibitors may not justify the risks for many users","volume":"170","author":"Katz","year":"2010","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.jsps.2018.11.002_b0075","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/MCG.0b013e318194c452","article-title":"Proton pump inhibitors: a better prescription is needed","volume":"43","author":"Khara","year":"2009","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.jsps.2018.11.002_b0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1742-1241.2004.00298.x","article-title":"Proton pump inhibitors: a survey of prescribing in an Irish general hospital","volume":"59","author":"Mat Saad","year":"2005","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.jsps.2018.11.002_b0085","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2710.2000.00312.x","article-title":"Overuse of proton pump inhibitors","volume":"25","author":"Naunton","year":"2000","journal-title":"J. Clin. Pharm. Ther."},{"issue":"10","key":"10.1016\/j.jsps.2018.11.002_b0090","doi-asserted-by":"crossref","first-page":"767","DOI":"10.20546\/ijcmas.2016.510.083","article-title":"Assessing the appropriate use of proton pump inhibitors amongst the outpatient Lebanese population","volume":"5","author":"Nawas","year":"2016","journal-title":"Int. J. Curr. Microbiol. App. Sci."},{"key":"10.1016\/j.jsps.2018.11.002_b0095","unstructured":"Nexium Control (esomeprazole) [summary of product characteristics]. Pfizer Consumer Healthcare Ltd., Kent, United Kingdom, 2014."},{"issue":"9","key":"10.1016\/j.jsps.2018.11.002_b0100","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00005650-199009000-00012","article-title":"The risks and benefits of an Rx-to-OTC switch. The case of over-thecounter H2-blockers","volume":"28","author":"Oster","year":"1990","journal-title":"Med. Care."},{"issue":"2014","key":"10.1016\/j.jsps.2018.11.002_b0105","first-page":"968430","article-title":"Attitude and knowledge of Indian emergency care residents towards use of proton pump inhibitors","volume":"19","author":"Padhy","year":"2014","journal-title":"Int. Sch. Res. Notices."},{"key":"10.1016\/j.jsps.2018.11.002_b0110","unstructured":"Pantoloc Control [summary of product characteristics], 2014. Takeda GmbH, Konstanz, Germany."},{"key":"10.1016\/j.jsps.2018.11.002_b0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5694\/j.1326-5377.2000.tb123871.x","article-title":"Concordance between use of proton pump inhibitors and prescribing guidelines","volume":"172","author":"Pillans","year":"2000","journal-title":"Med. J. Aust."},{"issue":"6","key":"10.1016\/j.jsps.2018.11.002_b0120","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/MOG.0b013e32833f2010","article-title":"Gastric secretion","volume":"26","author":"Schubert","year":"2010","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.jsps.2018.11.002_b0125","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/ndt\/18.3.570","article-title":"Overuse of acid suppressant drugs in patients with chronic renal failure","volume":"18","author":"Strid","year":"2003","journal-title":"Nephrol. Dial. Trans."},{"key":"10.1016\/j.jsps.2018.11.002_b0130","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2982.2012.01888.x","article-title":"PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis","volume":"24","author":"Weijenborg","year":"2012","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.jsps.2018.11.002_b0135","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0016-5085(00)70004-7","article-title":"Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome","volume":"118","author":"Wolfe","year":"2000","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.jsps.2018.11.002_b0140","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/archinternmed.2010.51","article-title":"Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal bleeding: effect of standardized guidelines on prescribing practice","volume":"170","author":"Yachimski","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jsps.2018.11.002_b0145","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1365-2036.2005.02454.x","article-title":"Long-term use of acid suppression started inappropriately during hospitalization","volume":"21","author":"Zink","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jsps.2018.11.002_b0150","unstructured":"Zolt [summary of product characteristics], 2013. Orion Corporation, Espoo, Finland."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016418305620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016418305620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:32:25Z","timestamp":1736184745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016418305620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1319016418305620"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2018.11.002","relation":{},"ISSN":["1319-0164"],"issn-type":[{"type":"print","value":"1319-0164"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attitude and knowledge of Saudi community pharmacists towards use of proton pump inhibitors","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2018.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Production and hosting by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}